chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feeling of manic depressive event. First a euphoric high day after dose. Then depressive feeling on second evening. Then near-syncope on day 3 post vaccine.  Patient felt a sense of impending dread while lying down and receiving physical therapy on TENS unit with heat. Then, a heat throughout the body, followed by sweating. Lastly, a near loss of consciousness. Patient was inverted with legs up. Patient requested an ambulance. Airway was clear. The incident occurred again 2 hours later with same presentation. Patient went to ED and received IV and vertigo medication. No episodes after.
pain and tingling in left arm and hand within 1 week of first dose, tingling/paresthesias in both hands and feet/lower legs 1 week after 2nd dose, daily, worse at night when trying to sleep
Case number PHEH2013US016160 is an initial spontaneous report received from a medical assistant on 26 JUL 2013 and a follow up report from the medical assistant received on 27 AUG 2013. This report refers to a 16-year-old female patient. Her medical history included allergies. Her vaccination history included vaccination with DTap on 27 FEB 1997 on 03 MAR 1997, on 26 JUL 1997, on 19 FEB 1998, 02 FEB 2001 and on 02 DEC 2010, Polio vaccine (unknown manufacturer) on 27 FEB 1997, on 26 JUL 1997, on 19 FEB 1998 and on 02 FEB 2001, MMR vaccine (other manufacturer) on 19 FEB 1998 and on 02 FEB 2001. HIB (other manufacturer) on 27 FEB 1997, 03 MAR 1997, 26 JUL 1997, 19 FEB 1998 and on 02 FEB 2001, Hepatitis B (other manufacturer) on 27 FEB 1997, 03 MAY 1997 and on 26 AUG 1997, VARICELLA (other manufacturer) on 26 NOV 2001 and on 02 DEC 2010, HPV (other manufacturer on 02 DEC 2010 and on 14 JUL 2012, Meningococcal (other manufacturer) on 02 DEC 2013 at a dose of 0.5 ml in the right deltoid intramuscularly on 01 JUL 2013 (at 12:38 PM). It was reported that the vaccine she received had a temperature excursion of 33 F for 4-6 hours. No adverse event was reported following the medication error. She was further vaccinated with another dose of MENVEO which had a temperature excursion (see related case: PHEH2013US016337). She received Pneumococcal (other manufacturer on 02 JUL 2013. It was reported that she needed to receive few more shots of seasonal influenza vaccine. Td and meningococcal vaccine in future.   Follow up report from the medical assistant received on 27 AUG 2013. Vaccination history and  recommended shots of vaccines in future were added. The MENVEO vaccine details (date of vaccination, batch number and site of vaccination were updated.
WITHIN 4 TO 6 WEEKS AFTER 1ST SHOT, EXPERIENCED TINGLING, PRICKING SENSATIONS IN ISOLATED AREAS OF BODY OR ACROSS ENTIRE BODY FOLLOWED BY A SHORT PERIOD OF PARALYSIS (LESS THAN ONE MINUTE). THESE RE-OCCURRED EVERY 1 TO 2 WEEKS UP TO THE PRESENT DATE. AT TIMES, SUSPECTED THAT THEY MAY HAVE COINCIDED WITH NIGHTLY STATIN PILL WHICH WERE TYPICALLY ASSOCIATED WITH "HOT FLASH" SIDE EFFECT ACROSS ENTIRE BODY. NO TREATMENT EXCEPT FOR OCCASSIONALLY SUSPENDING STATIN PILLS FOR SHORT PERIODS.
Fatigued; Massive headache; Nausea; Severe chills; Fever of 101F; Felt very achy; This is a spontaneous report from a contactable pharmacist, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 05May2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 14Apr2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05May2021 around 23:00, the patient felt really achy. On 06May2021, around midnight, the patient experienced severe chills and fever of 101F. On 06May2021, by around 03:00 to 04:00, the chills had reduced and fever was gone but the patient felt very achy and had a massive headache with nausea. By 08:00, the chills were essentially gone but the patient felt very achy and fatigued.  The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with zofran, tylenol and ibuprofen. The clinical outcome of the events fever of 101F and severe chills were resolved on 06May2021 at 04:00 and 08:00 respectively, while the outcome of the events headache, nausea and fatigued were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
This is a spontaneous report from a contactable nurse practitioner, with follow-up from the same contactable nurse, who reported about a few patients. This is the second of two reports from the same reporter. A 17-month-old male patient was administered a dose of PREVNAR 13 (lot 914516, expiration date 29Feb2012) by intramuscular route of administration on 08Apr2011. The relevant medical history and the concomitant medications were unknown. On 08Apr2011, the patient experienced high fever and had a febrile seizure at home. The patient was taken to a hospital Emergency Room on 08Apr2011, and was treated for fever. The febrile seizure and high fever resolved on an unknown date. Relevant laboratory data of the patients was unknown. Therapeutic measures taken in response to events were unknown. Follow-up (11Jul2011): This follow-up from a contactable nurse included: product details, patient details, onset dates and outcomes.
2nd hep B vaccine given 08/24/2001. She began feeling fatigued which led to her collapsing on 08/26/2001. Weakness in lower limbs got progressively worse and resulted in 2 hospitalizations and 7 months in a wheel chair. Correlation between vaccine and symptoms discovered 05/12/2002 by the doctor. Much better.
Joint pain; Muscle pain; Headache; Fever (100.7 F); Fatigue; This is a spontaneous report from a non-contactable Other Healthcare professional (HCP).  A 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot # EK5730), intramuscular, on 18Dec2020 at 12:30 PM at single dose for COVID-19 immunisation. Vaccine location was right arm. The patient was vaccinated at hospital, age at vaccination was 61-years-old. Medical history included the patient diagnosed with COVID 19 before vaccination.  On 19Dec2020 at 06:00 PM, the patient experienced joint pain, muscle pain, headache, fever (100.7 F) and fatigue. No treatment was administered for the events. The patient recovered from the events on an unknown date in Dec2020.   No follow-up attempts are possible. No further information is expected.
Fever to 101.3 axillary and vomitting at 11:00 with vaccine at 08:15.  Vomitting recurred over next 2 days, fever resolved.  Symptomatic treatment.
Itch; Breaking out in a rash from the vacanation; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itch) and VACCINATION SITE RASH (Breaking out in a rash from the vacanation) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itch) and VACCINATION SITE RASH (Breaking out in a rash from the vacanation). At the time of the report, PRURITUS (Itch) and VACCINATION SITE RASH (Breaking out in a rash from the vacanation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.   No treatment medications were reported.   Reporter did not allow further contact
Article states seizures from vaccination; Product complaint; This serious case was reported by a consumer and described the occurrence of seizures in a 10-month-old male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On 13-DEC-2016, an unknown time after receiving Bexsero, the patient experienced seizures (Verbatim: Article states seizures from vaccination) (serious criteria hospitalization and GSK medically significant). On an unknown date, the patient experienced pharmaceutical product complaint (Verbatim: Product complaint). The outcome of the seizures was not reported and the outcome of the pharmaceutical product complaint was unknown.   The reporter considered the seizures to be related to Bexsero and Bexsero Pre-Filled Syringe Device.     The company considered the seizures to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-JUN-2023 The patient was in hospital for the article states seizures from vaccination. The patient experienced seizures that could be linked to meningitis b vaccine states the child had seizures as a result of the vaccination.
Torso Sensitivity- when torso is slightly touched, patient feels a burning sensation. Patient attributed this to starting a new vitamin and went to a dermatologist (name unknown to nurse) and dermatologist told patient that monkeypox vaccine caused symptoms, though patient is unable to pinpoint exact date of symptom onset.
On 4/11/2021, woke up at normal time and began vomiting. This happened at least 3 days a week. Began having headaches, nosebleeds, earaches, pain in back of head, toothaches, anxiety, depression, hyperactivity. 4/30 PTSD, ADHD, sensory overload, unable to function. In May, I went to ENT specialist who said it was my teeth. In May, I went to dentist, and they found nothing. More ear, jaw, tooth pain, and headaches. Symptoms never resolved and couldn't get answers.  Finally went to see a doctor that did upper and lower GI scope and found Barret's Esophagus.
Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient fainted and hit her head on immunization chair and floor.
Very itchy, big raised bump on arm, red, sore, now going on 4 days
This spontaneous report was received from a medical assistance regarding an unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated improperly stored with VARIVAX (Merck) lot # L0445426, expiration date-09-NOV-2017, lot no. L040423, expiration date- 15-OCT-2017. No adverse event was reported. The outcome of the event was unknown. Temperature and time frame was 30.2F for 48 hours and 42F for 48 hours. Cumulative excursion was 42F for 96 hours. Yes it was administered and no previous temperature excursion. Additional information has been requested.
Moderma COVID- 19 Vaccine EUA    Red itchy rash all over body. Received shot on 01.12/21.   Received  MethylPREDNISolone tablets on 01/14/2021.
so weak and so tired; cannot go poop for 2 days; not very clear, cloudy mind; he has to use the walker; he did not drink and was dehydrated; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (so weak and so tired), CONSTIPATION (cannot go poop for 2 days), VISION BLURRED (not very clear, cloudy mind), GAIT INABILITY (he has to use the walker) and DEHYDRATION (he did not drink and was dehydrated) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history povided).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (so weak and so tired), CONSTIPATION (cannot go poop for 2 days), VISION BLURRED (not very clear, cloudy mind), GAIT INABILITY (he has to use the walker) and DEHYDRATION (he did not drink and was dehydrated). At the time of the report, FATIGUE (so weak and so tired), CONSTIPATION (cannot go poop for 2 days), VISION BLURRED (not very clear, cloudy mind), GAIT INABILITY (he has to use the walker) and DEHYDRATION (he did not drink and was dehydrated) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Blood test: measured blood test and it's due to his he cannot go poop for 2 days. On 27-Jan-2021, Computerised tomogram: normal ct scan looked normol.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
64-year-old female presented to the emergency department complaining of face feeling swollen in her throat feeling scratchy swollen with difficulty swallowing.  Patient had the first Pfizer vaccine about 9 hours ago that afternoon.  Just about 30 minutes prior to arrival started feeling funny.  Patient called to see if she could take some Benadryl.  She was told she should not take ibuprofen at the vaccination site.  She was supposed to take Tylenol only.  No fever positive chills just does not feel well.  Patient states she is got the vaccination in the left arm. she was observed and sent home.
Approx. 1.5 hours after vaccination she returned to the COVID site and reported HA, L arm numbness. The RN noted "A/O, VSS, site w/o redness, L arm swollen, can move arm. pulse strong, cap refill WNL, skin W&D. Reports nausea, released with dad to home." Pt was recommended to go to the ED or urgent care with any worsening symptoms, home with family.
Heart started racing/rapid heart beat; Trouble breathing/shortness of breath; This spontaneous case was reported by a patient and describes the occurrence of PALPITATIONS (Heart started racing/rapid heart beat) and DYSPNOEA (Trouble breathing/shortness of breath) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003F21A and 003F21A) for COVID-19 vaccination.     The patient's past medical history included Asymptomatic COVID-19 (Patient had an asymptomatic infection.). Concurrent medical conditions included Stress and Anxiety.   On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2022, the patient experienced PALPITATIONS (Heart started racing/rapid heart beat) and DYSPNOEA (Trouble breathing/shortness of breath). At the time of the report, PALPITATIONS (Heart started racing/rapid heart beat) and DYSPNOEA (Trouble breathing/shortness of breath) outcome was unknown.            No concomitant information was reported.  The patient had history of COVID-19 infection however patient did not know when patient caught COVID-19 infection and said that he had an asymptomatic infection. Patient had COVID-19 antibodies prior to receiving the COVID-19 vaccine and that was evidence of a COVID-19 infection. No hospitalization occurred due to COVID-19. The patient went to the Emergency Room due to events.  The patient had a rapid heartbeat and shortness of breath on 21-Feb-2022 after booster dose. The patient was told at the hospital that adverse events were because of stress and anxiety and  booster dose. The patient had not diagnosed with myocarditis or pericarditis.  No treatment information was reported.   This case was linked to MOD-2022-523369 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2022: Follow-up received and included no new information.
PT VACCINATED WITH MODERNA 3/4/21 (LOT 030A21A) + 4/08/21 (LOT 0241B21A)
Progress Notes: Registered Nurse;     Pt reports rash covering both arms next day after first dose of Pfizer vaccine. Pt applied hydrocortizone cream and ice packs and rash cleared up in 24hrs. Pt in 30 min observation for her second COVID vaccine shot.
In February 2022, I had bloodwork done. The results indicated that my platelets were low, and so were my hemoglobin and red blood cells. I was then referred to a local hematologist who kept running bloodwork. At the end of May 2022, he had me undergo a bone marrow biopsy, which appeared normal. My blood levels weren't improving, though, so I sought a second opinion in January 2023. The results of the May biopsy were reviewed, and they found abnormalities when they did next generation sequencing. Another biopsy was conducted on 1/30/2023, and I was diagnosed with myelodysplastic syndrome. I was then transferred to a doctor specializing in that form of cancer, and I also consulted with other doctors about stem cell treatments. So far, I don't need any transfusions, chemotherapy, radiation, or stem cell transplant. I'm eligible for a bone marrow or stem cell transplant should I need it. However, since I don't have strong symptoms currently, we are just watching and waiting.
[Reddened], warm raised area around injection site; Reddened, [warm] raised area around injection site; This is a spontaneous case from, initially received from other health professional via agency (reference number: SEQ19-04292) on 09-Oct-2019, concerning a 57-year-old, female patient.   The patient's relevant medical history and concomitant medications were not reported.  On 08-Oct-2019, the patient was administered with Flucelvax Quadrivalent [influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route: intramuscular, anatomical location: left deltoid, batch number: 259808, and expiration date: 31-May-2020] for an influenza prophylaxis.  On an unspecified date, the patient experienced reddened, warm raised area around injection site.  At the time of initial reporting, the outcome for the events of vaccination site warmth and injection site redness was not reported.  The reporter assessed the case as non-serious and did not provide causality assessment to Flucelvax Quadrivalent.  This case is linked to cases 201905128 and 201905130 (the same reporter).  Non-significant follow up received via agency (reference number: SEQ19-05262) on 22-Nov-2019: Additional reference number were added. No changes in the narrative.; Sender's Comments: The patient experienced vaccination site warmth and injection site erythema after vaccination with the suspect product Flucelvax Quadrivalent. Chronology is plausible. No medical history, diagnostic findings and concomitant medications were reported. Considering all the above mentioned, , causal role of the suspect product is assessed as related.
This case was considered medically important (OMIC). Information regarding Prevnar was received from a healthcare professional regarding a 6 month old male patient who experienced possible anaphylactic reaction. The patient received a dose on 9/28/04. The patient also received a dose of Diphtheria/Tetanus Toxoids/Acellular Pertussis Vaccine and a dose of Influenza Virus Vaccine Polyvalent on 9/28/04. The patient's concurrent illness includes food allergy to eggs. Indication for Prevnar was immunization. Product was administered on 9/28/04. Dose regimen was 1 dose. Concomitant medications were not reported. Two hours after receiving vaccines on 9/28/04, the patient developed hives and eyelid swelling. The physician felt that the child had experienced a possible anaphylactic reaction. The patient was treated with Benadryl and recovered.
Vaccine was Thur 3/11 at noon.  Slight headache and pain at site of injection. Friday morning, was very dizzy.  Had walked into kitchen to get the thermometer.  My temp was 99. I got very dizzy and passed out for a second or two.  When I hit my head on a cabinet handle I came to.  At first I though I was in my bed and couldn't figure out what I had hit my head on.  There was blood coming from the wound. My husband came to help me.  We stopped the bleeding after a few minutes and I began icing my head.   I was still very dizzy and had an urge to use the bathroom.  I was afraid to get up. With my husband's help, I crawled to bathroom and he helped my onto toilet.  I had diarrhea.   At that point I was able to walk with help to my bed. I have had a mild to moderate headache since I had the vaccine.
About 1 month after I got the second Covid19 booster shot, I developed chronic hives that continue today. I went to my primary doctor who sent me to an allergy specialist who said she has been seeing this a lot about one month after the booster shots. I am now on Famotidine and Zyrtec through Sept. when I revisit the specialist. She thinks it's an immune system reaction to too many vaccines. I have had the following vaccines within the past year and a half. Covid19 1 on 2/3/21, Covid19 2 on 3/3/21, Flu short on 11/30/21, Covid19 booster on 11/6/21, Tetanus on 1/18/22, Covid19 2nd booster on 5/4/22, and Shingles vaccine on 6/2/22.
severe migraines and headaches; feels extremely tired; the right side of her face and head started feeling really numb; Tingling sensation from her cheek to down her neck; When she swallowed she felt like a lump on her throat on the right side; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (the right side of her face and head started feeling really numb), PARAESTHESIA (Tingling sensation from her cheek to down her neck), SENSATION OF FOREIGN BODY (When she swallowed she felt like a lump on her throat on the right side), CLUSTER HEADACHE (severe migraines and headaches) and FATIGUE (feels extremely tired) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HYPOAESTHESIA (the right side of her face and head started feeling really numb), PARAESTHESIA (Tingling sensation from her cheek to down her neck) and SENSATION OF FOREIGN BODY (When she swallowed she felt like a lump on her throat on the right side). On 30-Jan-2021, the patient experienced CLUSTER HEADACHE (severe migraines and headaches) and FATIGUE (feels extremely tired). On 30-Jan-2021, HYPOAESTHESIA (the right side of her face and head started feeling really numb) and SENSATION OF FOREIGN BODY (When she swallowed she felt like a lump on her throat on the right side) had resolved. At the time of the report, PARAESTHESIA (Tingling sensation from her cheek to down her neck), CLUSTER HEADACHE (severe migraines and headaches) and FATIGUE (feels extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.
Three days after patient received Moderna COVID-19 vaccine shot 1, He went to ER complaining of  heart palpitation. Patient were diagnosed of A-Fib. Patient were discharged on the same day with prescription of Flecainide 150mg to be used as needed for heart emergency. Patient didn't use the medicine and is doing ok. Patient stated that they have received the second shot on 06/17/2021at pharmacy with no adverse reaction.